Current research focuses on the soluble and high-level expression of biologically active recombinant human IL-29 protein in Escherichia coli. The codon-optimized IL-29 gene was cloned into the Champion™ pET SUMO expression system downstream of the SUMO tag under the influence of the T7 lac promoter. The expression of SUMO-fused IL-29 protein was compared in E. coli Rosetta 2(DE3), Rosetta 2(DE3) pLysS, and Rosetta-gami 2(DE3). The release of the SUMO fusion partner resulted in approximately 98 mg of native rhIL-29 protein with a purity of 99% from 1 l of fermentation culture. Purified rhIL-29 was found to be biologically active, as evaluated by its anti-proliferation assay. It was found that Champion™ pET SUMO expression system can be used to obtained high yield of biologically active soluble recombinant human protein compared to other expression vector.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235849PMC
http://dx.doi.org/10.1007/s10529-023-03402-xDOI Listing

Publication Analysis

Top Keywords

recombinant human
12
pet sumo
12
biologically active
12
active recombinant
8
il-29 protein
8
champion™ pet
8
sumo expression
8
expression system
8
protein compared
8
rosetta 2de3
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!